Anavex Life Sciences Corp. (AVXL) is currently at $11.14, up $2.51 or 29.08%
--Would be highest close since Feb. 7, 2023, when it closed at $11.75
--On pace for largest percent increase since Dec. 2, 2022, when it rose 35.85%
--Currently up two consecutive days; up 31.52% over this period
--Best two day stretch since the two days ending Dec. 2, 2022, when it rose 36.62%
--Up 17.76% month-to-date
--Up 19.66% year-to-date; on pace for best year since 2021, when it rose 221.11%
--Down 61.4% from its all-time closing high of $28.86 on June 28, 2021
--Up 24.47% from 52 weeks ago (Dec. 22, 2023), when it closed at $8.95
--Would be a new 52-week closing high
--Up 228.61% from its 52-week closing low of $3.39 on April 25, 2024
--Traded as high as $11.50; highest intraday level since Feb. 8, 2023, when it hit $11.90
--Up 33.26% at today's intraday high; largest intraday percent increase since Dec. 2, 2022, when it rose as much as 49.15%
All data as of 1:17:28 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 23, 2024 13:19 ET (18:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。